Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.

Cabozantinib as Subsequent Therapy to an Immune Checkpoint Based Therapy in Renal Cell Carcinoma

NCT04714697 ·Status: UNKNOWN ·Phase: PHASE2

Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors

NCT03945773 ·Status: COMPLETED ·Phase: PHASE2

Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)

NCT04106349 ·Status: ACTIVE_NOT_RECRUITING

Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients

NCT05241561 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint Inhibitors

NCT04353765 ·Status: COMPLETED

A Study to Collect Pre-existing Data on the Administration of Cabozantinib in Participants With Advanced Renal Cell Carcinoma (aRCC) Who Initiated Cabozantinib in 2nd Line in a Real-life Clinical Setting in France.

NCT05444933 ·Status: COMPLETED

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

NCT03937219 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Spanish Real-World Evidence Cabozantinib

NCT04510688 ·Status: COMPLETED

Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England

NCT04637204 ·Status: COMPLETED

Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases

NCT03967522 ·Status: COMPLETED ·Phase: PHASE2

Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma

NCT04416646 ·Status: COMPLETED

Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Anti-angiogenic Regimen

NCT03013335 ·Status: COMPLETED ·Phase: PHASE2

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

NCT07011719 ·Status: RECRUITING ·Phase: PHASE3

Cabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing Combination

NCT04957160 ·Status: COMPLETED

Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer

NCT03455452 ·Status: ACTIVE_NOT_RECRUITING

CaboCHECK - Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional Study

NCT04147143 ·Status: TERMINATED

Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer

NCT06377722 ·Status: TERMINATED ·Phase: PHASE2

A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Renal Cell Carcinoma

NCT03339219 ·Status: COMPLETED ·Phase: PHASE2

Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma

NCT04804813 ·Status: COMPLETED

caBozantinib in cOllectiNg ductS Renal Cell cArcInoma

NCT03354884 ·Status: COMPLETED ·Phase: PHASE2

Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib

NCT06548867 ·Status: RECRUITING

Prospective Translational Study Investigating Predictors of Outcome in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab (I-Rene Trial)

NCT04891055 ·Status: UNKNOWN

Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer

NCT01835158 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases

NCT05048212 ·Status: RECRUITING ·Phase: PHASE2

Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases

NCT01444807 ·Status: UNKNOWN ·Phase: PHASE2